Canvas Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
HCM
AAMU
HPC
CRM
CNB
Canvas Wealth Advisors's ABBV Position: Q2 2026 in Review
Canvas Wealth Advisors increased its AbbVie (ABBV) stake by 22% in Q2 2026, buying an estimated $99.2K and bringing the position to 2,605 shares worth $656K. The position accounts for 0.09% of the portfolio, ranked #112.
Canvas Wealth Advisors first reported a position in ABBV in Q1 2021 and has held it in 16 quarters since. 1,174 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Canvas Wealth Advisors held 2,605 shares of AbbVie worth $656K as of Q2 2026.
- Canvas Wealth Advisors bought 461 AbbVie shares in Q2 2026, an estimated $99.2K.
- AbbVie made up 0.09% of Canvas Wealth Advisors's portfolio in Q2 2026, its #112 holding.
- Canvas Wealth Advisors first reported a position in AbbVie in Q1 2021 and has held it in 16 quarters since.
- 1,174 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Canvas Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.